0.50
-0.025(-4.76%)
Currency In GBp
Address
Avon House
Penarth, CF64 2EZ
United Kingdom of Great Britain and Northern Ireland
Phone
44 207 9338780
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
19
First IPO Date
November 03, 2020
| Name | Title | Pay | Year Born |
| Ms. Sara jane Barrington A.C.A., A.C.I.M. | Chief Executive Officer & Executive Director | 403,321 | 1967 |
| Mr. David Mark Anderson | Chief Financial Officer & Company Secretary | 0 | 1963 |
Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.
